Skip to main content

Table 2 The association between GBP5 protein expression and clinicopathological parameters of GC

From: Identification of differential proteomics in Epstein-Barr virus-associated gastric cancer and related functional analysis

Parameters GBP5 expression P
Positive (%) Negative (%)
Lauren classification    0.067
 Diffuse type 73 (90.1) 109 (80.7)  
 Intestinal type 8 (9.9) 26 (19.3)  
Histological type    0.057
 Low/un-differentiated 75 (90.4) 109 (80.7)  
 High/middle-differentiated 8 (9.6) 26 (19.3)  
Depth of invasion    0.042
 Muscularis + Serosa 73 (86.9) 102 (75.6)  
 Mucosa + Submucosa 11 (13.1) 33 (24.4)  
Growth mode    0.264
 Diffuse/invasive 63 (75.0) 109 (81.3)  
 Nest 21 (25.0) 25 (18.7)  
Lymphatic metastasis    0.882
 Positive 52 (63.4) 83 (62.4)  
 Negative 30 (36.6) 50 (37.6)  
Peritumor lymphocyte infiltration   1.000
 Positive 82 (98.8) 130 (97.7)  
 Negative 1 (1.2) 3 (2.3)  
Vascular cancer embolus    0.021
 Positive 53 (63.1) 63 (47.0)  
 Negative 31 (36.9) 71 (53.0)  
Perineural invasion    0.334
 Positive 66 (78.6) 96 (72.7)  
 Negative 18 (21.4) 36 (27.3)  
Extranodal tumor implantation    0.011
 Positive 11 (13.3) 5 (3.8)  
 Negative 72 (86.7) 125 (96.2)  
  1. GC gastric cancer
  2. The results are in bold if P < 0.05